Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Why Does Aspirin Fail in Secondary Cerebrovascular Prevention? A Multicenter Prospective Case - Control Study

NCT05247931 is registered in ClinicalTrials.gov with Fadoi Foundation, Italy as lead sponsor.

NCT NCT05247931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05247931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Why Does Aspirin Fail in Secondary Cerebrovascular Prevention? A Multicenter Prospective Case - Control Study
Lead sponsor
Fadoi Foundation, Italy
Phase
Observational
Overall status
Unknown status
Start date
November 7, 2019
Completion date
April 30, 2022
Enrollment
100 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrovascular disease